Personalized Pathology & Cancer Therapy
1 – 10 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Cellular and molecular cartography of muscle-invasive bladder cancer: Who benefits from neoadjuvant chemotherapy?
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol
- Contribution to journal › Article
- 2024
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
- Contribution to journal › Article
-
Mark
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
- Contribution to journal › Article
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
- Contribution to journal › Article
- 2022
-
Mark
A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
- Contribution to journal › Article
-
Mark
High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
- Contribution to journal › Article
